Research
Research
Virology and parasitology — two pillars, one laboratory.
Malaria mother–child cohort
Across three African countries we built mother–child cohorts to study placental malaria and the wider burden of malaria — vertical transmission, severe disease in children, and drug resistance.
DR Congo Nigeria Kenya
Read more
Building a research hub in DR Congo
Under an AMED program, in partnership with INRB (DR Congo), we are building a core hub for infectious-disease research in sub-Saharan Africa — advancing diagnostics, surveillance, and training together.
DR Congo
Read more
Mpox integrated study
Combining a human Clade I cohort with our multi-layered omics platform, we elucidate the molecular basis of protective immunity to inform diagnostics and next-generation vaccines and antibodies.
DR Congo
Read more
Chagas disease: vectors and cardiomyopathy
Nationwide vector surveillance and NGS bloodmeal analysis in El Salvador demonstrate active transmission risk to humans, while cardiomyocyte models dissect the pathology of Chagas cardiomyopathy.
El Salvador
COVID-19 humoral immunity
We comprehensively analyze humoral immunity to SARS-CoV-2 across infection, vaccination, and hybrid immunity — revealing antibody avidity maturation and epitope breadth, and establishing optimal serological assays.
Japan
Surveillance of undiagnosed infections
Using NGS metagenomics and comprehensive antibody profiling (PhIP-Seq), we search for the pathogens behind undiagnosed infections and build systems to monitor unknown pathogens in endemic regions.
DR Congo
Trypanosome drug discovery
Targeting the alternative oxidase (AOX) — essential to the parasite yet absent in humans — we develop selective ascofuranone-derived inhibitors, bridging molecular science to medicines.